After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Sana Biotechnology’s hypoimmune platform enables it to make a series of genetic modifications to cells, rendering the cells ...

But positive early results from a trial run by the drug company Vertex Pharmaceuticals based in Boston, Massachusetts, have spawned a rush of optimism for diabetes. Stem-cell biologist Douglas ...

Abu Dhabi Stem Cells Centre (ADSCC) announced promising results of a revolutionary advancement in the management of diabetes, successfully performing umbilical cord-derived mesenchymal stem cell ...

The gold standard treatment for type 1 diabetes mellitus is intensive insulin replacement. An alternative approach is to suppress the autoimmune reaction against pancreatic β-cells; this ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

Mesenchymal stem cells are vital in the treatment of cystic fibrosis, liver cirrhosis, lung diseases, diabetes and many other medical conditions. [iStockphoto] For many people, complex medical ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with ...

opening the door to developing a means of one day tackling complex diseases like diabetes and Parkinson’s disease. Arguably, stem cells represent the future of healthcare and medical research.

A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...